BACKGROUND: Novel treatment options for eosinophilic esophagitis (EoE) are needed. Previous studies have assessed mepolizumab (mepo), a monoclonal antibody against IL-5, with mixed results in EoE, and the efficacy of mepo in an adult and adolescent population has yet to be fully examined…
Speakers
University of North Carolina School of Medicine
Amsterdam UMC, University of Amsterdam
Mount Sinai School of Medicine
Northwestern University - The Feinberg School of Medicine